157 related articles for article (PubMed ID: 9831960)
21. Epstein Barr Virus detection and latent membrane protein 1 in oral hairy leukoplakia in HIV+ Venezuelan patients.
González X; Correnti M; Rivera H; Perrone M
Med Oral Patol Oral Cir Bucal; 2010 Mar; 15(2):e297-302. PubMed ID: 20038918
[TBL] [Abstract][Full Text] [Related]
22. Expression of Epstein-Barr virus latent genes in oral epithelium: determinants of the pathogenesis of oral hairy leukoplakia.
Walling DM; Ling PD; Gordadze AV; Montes-Walters M; Flaitz CM; Nichols CM
J Infect Dis; 2004 Jul; 190(2):396-9. PubMed ID: 15216478
[TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr virus oral shedding and viremia and their association with oral hairy leukoplakia in HIV+ individuals.
Rosseto JHF; Tenório JR; Mamana AC; Tozetto-Mendoza TR; Andrade NS; Braz-Silva PH; Ortega KL
Oral Dis; 2023 Mar; 29(2):796-802. PubMed ID: 34379873
[TBL] [Abstract][Full Text] [Related]
24. Human immunodeficiency virus-positive individuals with oral hairy leukoplakia are able to mount cytotoxic T lymphocyte responses to Epstein-Barr virus.
de Jong A; Palefsky JM; Stites DP; Nakagawa M
Oral Dis; 2000 Jan; 6(1):40-7. PubMed ID: 10673787
[TBL] [Abstract][Full Text] [Related]
25. Oral hairy leukoplakia in healthy immunocompetent patients: a small case series.
Shanahan D; Cowie R; Rogers H; Staines K
Oral Maxillofac Surg; 2018 Sep; 22(3):335-339. PubMed ID: 30079439
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of Epstein-Barr virus and human papillomavirus in oral mucosa of HIV-infected patients.
Adler-Storthz K; Ficarra G; Woods KV; Gaglioti D; DiPietro M; Shillitoe EJ
J Oral Pathol Med; 1992 Apr; 21(4):164-70. PubMed ID: 1318379
[TBL] [Abstract][Full Text] [Related]
27. Oral hairy leukoplakia diagnosis by Epstein-Barr virus in situ hybridization in liquid-based cytology.
Braz-Silva PH; Santos RT; Schussel JL; Gallottini M
Cytopathology; 2014 Feb; 25(1):21-6. PubMed ID: 23445399
[TBL] [Abstract][Full Text] [Related]
28. Oral EBV and KSHV infection in HIV.
Webster-Cyriaque J; Duus K; Cooper C; Duncan M
Adv Dent Res; 2006 Apr; 19(1):91-5. PubMed ID: 16672557
[TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr virus BMRF-2 and BDLF-3 expression in hairy leukoplakia.
Palefsky JM; Peñaranda ME; Pierik LT; Lagenaur LA; MacPhail LA; Greenspan D; Greenspan JS
Oral Dis; 1997 May; 3 Suppl 1():S171-6. PubMed ID: 9456683
[TBL] [Abstract][Full Text] [Related]
30. Detection of Epstein-Barr virus-DNA in tongue epithelium of human immunodeficiency virus-infected patients.
Näher H; Gissmann L; von Knebel Doeberitz C; von Knebel Doeberitz M; Greenspan JS; Greenspan D; Petzoldt D; Edler L; Freese UK
J Invest Dermatol; 1991 Sep; 97(3):421-4. PubMed ID: 1651968
[TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus in oral mucosa from human immunodeficiency virus positive patients.
Santos L; Azevedo K; Silva L; Oliveira L
Rev Assoc Med Bras (1992); 2014; 60(3):262-9. PubMed ID: 25004273
[TBL] [Abstract][Full Text] [Related]
32. Tissue distribution of Epstein-Barr virus genotypes in hosts coinfected by HIV.
Triantos D; Leao JC; Porter SR; Scully CM; Teo CG
AIDS; 1998 Nov; 12(16):2141-6. PubMed ID: 9833854
[TBL] [Abstract][Full Text] [Related]
33. Persistence and transition of Epstein-Barr virus genotypes in the pathogenesis of oral hairy leukoplakia.
Walling DM; Etienne W; Ray AJ; Flaitz CM; Nichols CM
J Infect Dis; 2004 Jul; 190(2):387-95. PubMed ID: 15216477
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr virus: biology and disease.
Cruchley AT; Williams DM; Niedobitek G; Young LS
Oral Dis; 1997 May; 3 Suppl 1():S156-63. PubMed ID: 9456681
[TBL] [Abstract][Full Text] [Related]
35. Oral hairy leukoplakia: an Epstein-Barr virus-associated disease of patients with HIV.
Walling DM
Res Initiat Treat Action; 2000 Dec; 6(4):10-5. PubMed ID: 11708168
[TBL] [Abstract][Full Text] [Related]
36. Risk factors associated with Epstein-Barr virus replication in oral epithelial cells of HIV-infected individuals.
Boulter AW; Soltanpoor N; Swan AV; Birnbaum W; Johnson NW; Teo CG
AIDS; 1996 Aug; 10(9):935-40. PubMed ID: 8853725
[TBL] [Abstract][Full Text] [Related]
37. Effect of Epstein-Barr virus replication on Langerhans cells in pathogenesis of oral hairy leukoplakia.
Walling DM; Flaitz CM; Hosein FG; Montes-Walters M; Nichols CM
J Infect Dis; 2004 May; 189(9):1656-63. PubMed ID: 15116302
[TBL] [Abstract][Full Text] [Related]
38. Lack of evidence for local immune activity in oral hairy leukoplakia and oral wart lesions.
Lilly EA; Cameron JE; Shetty KV; Leigh JE; Hager S; McNulty KM; Cheeks C; Hagensee ME; Fidel PL
Oral Microbiol Immunol; 2005 Jun; 20(3):154-62. PubMed ID: 15836516
[TBL] [Abstract][Full Text] [Related]
39. Detection of human papillomavirus and Epstein-Barr virus DNA sequences in oral mucosa of HIV-infected patients by the polymerase chain reaction.
Snijders PJ; Schulten EA; Mullink H; ten Kate RW; Jiwa M; van der Waal I; Meijer CJ; Walboomers JM
Am J Pathol; 1990 Sep; 137(3):659-66. PubMed ID: 2169191
[TBL] [Abstract][Full Text] [Related]
40. Significance of Epstein-Barr virus (HHV-4) and CMV (HHV-5) infection among subtype-C human immunodeficiency virus-infected individuals.
Sachithanandham J; Kannangai R; Pulimood SA; Desai A; Abraham AM; Abraham OC; Ravi V; Samuel P; Sridharan G
Indian J Med Microbiol; 2014; 32(3):261-9. PubMed ID: 25008818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
